表达Rv0976c的子单位疫苗对结核的保护效果
Ziwei Zhou1, Dan Chen2, Fuzeng Chen1
1State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai 200433, China.
Vaccines
|August 28, 2025
概括
Rv0976c 是一种新的结核疫苗抗原. 它在小鼠中诱导了强大的细胞免疫和抗体反应,并保护了对 Mycobacterium 结核病的挑战,这表明它有可能在未来开发疫苗.
科学领域:
- 免疫学
- 疫苗学
- 微生物学
背景情况:
- 开发有效的结核病疫苗对于全球健康至关重要.
- 诱导细胞免疫的子单位疫苗是一个有前途的策略.
- 鉴定新型免疫抗原是新疫苗开发的关键.
研究的目的:
- 选七种候选抗原,以检测它们在亚单元结核病疫苗开发中的潜力.
- 评估所选抗原的免疫性和保护性,特别是Rv0976c.
主要方法:
- 用净化蛋白质 (PPE19,PPE50,FadD21,Rv1505c,Rv1506c,Rv2035,Rv0976c) 或表达Rv0976c的DNA疫苗免疫小鼠.
- 对抗原特异性Th1细胞免疫反应和IgG水平进行了评估.
- 用Rv0976cDNA疫苗接种的小鼠接受了Mycobacterium tuberculosis (M. tb) 的挑战,以评估其保护效果.
主要成果:
- 与PPE19,PPE50和FadD21一起,Rv0976c诱导了强大的抗原特异性Th1细胞免疫反应.
- 与Ag85A相比,Rv0976c刺激了较高的IgG抗体水平,并在结核病患者的血清中显示出反应性.
- Rv0976c DNA 疫苗提供了与主要抗原相比或更高的抗M.
结论:
- Rv0976c被认为是开发结核病疫苗的高保护性抗原.
- 需要进一步研究将Rv0976c与其他抗原结合,并将其用作BCG强化剂或治疗疫苗.
更多相关视频
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10.7K
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.4K
相关概念视频
Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
Pulmonary Tuberculosis IV
202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Pulmonary Tuberculosis II
343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343
Cross-reactivity
31.5K
Overview
31.5K
